FDA Adverse Event Summary report: N

CEEON

MDR report key: 486427 · Received October 1, 2003

Report

Report Number
9614546-2003-00054
Date Received
October 1, 2003
Report Date
September 24, 2003
Manufacturer
PHARMACIA & UPJOHN GRONINGEN BV
Product Code
HQL
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IS
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

PUPILLARY BLOCK [PUPILLARY DISORDER NOS]. A LITERATURE ARTICLE (GATON DD ET AL, BRITISH JOURNAL OF OPHTHALMOLOGY 2003; 87:1109-1111) REPORTED THAT A PT, SUFFERING FROM ANGLE CLOSURE GLAUCOMA, EXPERIENCED PUPILLARY BLOCK FOLLOWING POSTERIOR CHAMBER INTRAOCULAR LENS (IOL) IMPLANTATION. THE LENS WAS IMPLANTED, ON AN UNK DATE, AFTER EXTRACAPSULAR CATARACT EXTRACTION AND FIVE YEARS LATER PUPILLARY BLOCK WAS DIAGNOSED BASED ON THE APPEARANCE OF IRIS BOMBE AND A SHALLOW ANTERIOR CHAMBER WITH A FIXED, NON-REACTING PUPIL AND INCREASED INTRAOCULAR PRESSURE (IOP) UP TO 56MMHG. THE PT WAS TREATED INITIALLY WITH TOPICAL BETA-BLOCKERS, TOPICAL ALFA-ADRENERGIC AGONIST AND LATANOPROST (XALATAN) THEN WITH NEODYMIUM-YAG LASER PERIPHERAL IRIDOTOMY REPEATED TWICE. THE FINAL IOP WAS 6MMHG AND THE VISUAL ACUITY 20/150. THE EVENT PUPILLARY BLOCK IS LISTED VS CDS. THE REPORTING PHYSICIAN CONSIDERED THE EVENT TO BE RELATED TO THE IOL IMPLANTATION. THE COMPANY AGREES ON THAT ASSESSMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CEEON INTRAOCULAR LENS HQL PHARMACIA & UPJOHN GRONINGEN BV 911A UNK

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention